NCT04332653 2026-03-09
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
Phase 1/2 Completed
Clinical Trials
31 trialsNCT05795595 2025-11-26
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
Phase 1/2 Completed
NCT05340569 2025-03-20
DWI-PDAC
Laval University
Phase NA Completed
NCT01554397 2024-11-29
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
University of California, San Diego
Phase 2/3 Completed
NCT02164461 2024-05-20
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Phase 1 Completed
NCT05375136 2024-03-25
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
Eisai Inc.
Completed
NCT00614211 2023-04-18
LACC
Queensland Centre for Gynaecological Cancer
Phase NA Completed
NCT02759588 2023-01-05
GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer
Genelux Corporation
Phase 1/2 Completed
NCT02440425 2022-10-07
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT03562897 2022-07-06
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
Phase 2 Completed
NCT01554410 2022-02-17
Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma
University of California, San Diego
Phase 1 Completed
NCT00420381 2020-12-19
Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer
Eli Lilly and Company
Phase 2 Completed
NCT01519869 2020-12-14
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
University of Kentucky
Phase 2 Completed
NCT00216372 2020-11-05
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis
Ipsen
Phase 3 Completed
NCT02082886 2020-01-29
HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry
Edward-Elmhurst Health System
Completed
NCT01991808 2019-11-26
Suitability of DCE-MRI for Detection of Vascular Changes After VBT
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT01610869 2019-05-29
METRO-BIBF
University College, London
Phase 2 Completed
NCT00862355 2019-05-03
Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer
Sun Pharma Advanced Research Company Limited
Phase 1 Completed
NCT00096408 2019-03-20
Laparoscopic Approach to Cancer of the Endometrium
Queensland Centre for Gynaecological Cancer
Phase 3 Completed
NCT00326885 2018-10-17
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Neovii Biotech
Phase 2 Completed
NCT01253681 2015-10-14
Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer
Amgen
Phase 1 Completed
NCT00770536 2015-09-29
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
Amgen
Phase 1 Completed
NCT01379534 2015-05-20
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Novartis
Phase 2 Completed
NCT00315159 2015-01-12
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
Women and Infants Hospital of Rhode Island
Phase NA Completed
NCT00816764 2013-02-27
A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer
Astellas Pharma Inc
Phase 1 Completed
NCT00050440 2013-01-08
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2 Completed
NCT01041235 2012-09-06
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Azaya Therapeutics, Inc.
Phase 1 Completed
NCT00377429 2012-07-19
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
Neovii Biotech
Phase 2 Completed
NCT00332696 2011-09-23
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
Novartis
Phase 2 Completed
NCT00112307 2009-09-17
Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
Brigham and Women's Hospital
Phase NA Completed
NCT00001569 2008-03-04
Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
Phase 1 Completed